In May 2008, the Department of Health and Human Services announced the launch of the Sentinel Initiative by the US Food and Drug Administration (FDA) to create the Sentinel System, a national electronic system for medical product safety surveillance. This system complements existing FDA surveillance capabilities that track adverse events reported after the use of FDA regulated products by allowing the FDA to proactively assess the safety of these products.
|Original language||English (US)|
|Number of pages||4|
|Journal||Clinical Pharmacology and Therapeutics|
|State||Published - Mar 1 2016|
ASJC Scopus subject areas
- Pharmacology (medical)